Myeloid FTH1 Deficiency Protects Mice From Colitis and Colitis-associated Colorectal Cancer via Reducing DMT1-Imported Iron and STAT3 Activation
Inflammatory Bowel Diseases · 2023
DOI: 10.1093/ibd/izad009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2023. Verfasst von Zhaoli Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM, 87131, USA. Hauptthemen laut MEDLINE: Colitis-Associated Neoplasms, Colitis, Colorectal Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health, American Cancer Society.
Abstract (Originalsprache)
Background
Myeloid cells are critical for iron and immune homeostasis. Ferritin heavy chain (FTH1) is essential for intracellular iron storage. Myeloid FTH1 is important in the pathogenesis of many inflammatory diseases. However, the role of myeloid FTH1 in colitis and colitis-associated cancer has not been determined.
Methods
Myeloid FTH1 deficient and wild-type mice were treated with dextran sodium sulfate (DSS) or azoxymethane (AOM)-DSS to compare their susceptibility to acute colitis or colitis-associated cancer.
Results
Myeloid FTH1-deficient mice fed with a high-iron diet were less susceptible to DSS-induced acute colitis than wild type mice. Mechanistic studies showed that myeloid FTH1 deficiency resulted in lower expression of an iron uptake protein divalent metal transporter 1 (DMT1) and active phosphorylated signal transducer and activator of transcription 3 (STAT3) in the colon tissues. Our studies also showed that pharmacological STAT3 reactivation restored the susceptibility of myeloid FTH1-deficient mice to DSS-induced acute colitis. Consistently, myeloid FTH1-deficient mice fed with a high-iron diet had reduced DMT1, phosphorylated STAT3 and inflammation in their colon tissues, and were less susceptible to colitis-associated colorectal cancer.
Conclusions
Our study demonstrated that myeloid FTH1 is required for colitis and colitis-associated colorectal cancer via maintaining of DMT1-iron-STAT3 signaling activation under excess iron condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM, 87131, USA.
- Department of Pathology, University of New Mexico, Albuquerque, NM 87131, USA.
ORCID-Profile: Xiang Xue
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- American Cancer Society
Zitieren
APA
Liu, Z., Arcos, M., Martin, D. R., & Xue, X. (2023). Myeloid FTH1 Deficiency Protects Mice From Colitis and Colitis-associated Colorectal Cancer via Reducing DMT1-Imported Iron and STAT3 Activation. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad009
Vancouver
Liu Z, Arcos M, Martin DR, Xue X. Myeloid FTH1 Deficiency Protects Mice From Colitis and Colitis-associated Colorectal Cancer via Reducing DMT1-Imported Iron and STAT3 Activation. Inflammatory Bowel Diseases. 2023. doi:10.1093/ibd/izad009
BibTeX
@article{Liu2023,
author = {Liu, Zhaoli and Arcos, Mariella and Martin, David R and Xue, Xiang},
title = {Myeloid FTH1 Deficiency Protects Mice From Colitis and Colitis-associated Colorectal Cancer via Reducing DMT1-Imported Iron and STAT3 Activation},
journal = {Inflammatory Bowel Diseases},
year = {2023},
doi = {10.1093/ibd/izad009}
}
EUVIMED